The Mediterranean diet pattern has strong evidence for cardiovascular health and can support sustainable weight loss
[11] [12] Currently available GLP-1 receptor agonists in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist
This violation of the "Segregation of Duties" principle is a primary driver of data integrity enforcement under 211.68(b)
PlexusDx does not prescribe or recommend specific medication regimensyour qualified healthcare provider should make all treatment decisions based on comprehensive clinical assessment
,
Retrieved September 12, 2025, from Mounjaro Official Patient Website